Bill Text: MI HB4354 | 2021-2022 | 101st Legislature | Engrossed
Bill Title: Insurance: health insurers; coverage for orally administered anticancer chemotherapy; provide equal treatment for. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406v. TIE BAR WITH: HB 4347'21
Spectrum: Strong Partisan Bill (Republican 19-2)
Status: (Engrossed - Dead) 2021-03-25 - Referred To Committee On Health Policy And Human Services [HB4354 Detail]
Download: Michigan-2021-HB4354-Engrossed.html
Substitute For
A bill to amend 1956 PA 218, entitled
"The insurance code of 1956,"
(MCL 500.100 to 500.8302) by adding section 3406v.
the people of the state of michigan enact:
Sec. 3406v. (1) A health insurance policy delivered, issued for delivery, or renewed in this state that provides coverage for prescribed orally administered anticancer medications and intravenously administered or injected anticancer medications must ensure either of the following:
(a) That financial requirements applicable to prescribed orally administered anticancer medications are not more restrictive than the financial requirements that apply to intravenously administered or injected anticancer medications that are covered by the health insurance policy.
(b) That the co-pay or coinsurance for orally administered anticancer medication does not exceed $150.00 per 30-day supply. Beginning January 1, 2024 and each January 1 thereafter, the department shall adjust the financial requirement described in this subdivision by an amount determined by the state treasurer that reflects the cumulative annual change in the prescription drug index of the medical care component of the United States Consumer Price Index.
(2) An insurer cannot achieve compliance with this section by increasing cost-sharing requirements, reclassifying benefits with respect to anticancer medications, or imposing more restrictive treatment limitations on prescribed orally administered anticancer medications or intravenously administered or injected anticancer medications covered under a health insurance policy described in subsection (1).
(3) This section does not prohibit an insurer from applying utilization management techniques, including prior authorization, step therapy, limits on quantity dispensed, and days' supply per fill for any administered anticancer medication.
(4) As used in this section:
(a) "Anticancer medication" means a medication used to kill, slow, or prevent the growth of cancerous cells.
(b) "Cost-sharing requirement" means deductibles, copayments, coinsurance, out-of-pocket expenses, aggregate lifetime limits, and annual limits.
(c) "Treatment limitation" means limits on the frequency of treatment, days of coverage, or other similar limits on the scope or duration of treatment. Treatment limitation does not include the application of utilization management techniques described in subsection (3).
Enacting section 1. This amendatory act applies to health insurance policies delivered, issued for delivery, or renewed in this state after December 31, 2022.
Enacting section 2. This amendatory act does not take effect unless House Bill No. 4347 of the 101st Legislature is enacted into law.
